busulfan has been researched along with Hemophilia A in 3 studies
Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Merlin, S | 1 |
Akula, S | 1 |
Cottonaro, A | 1 |
Garcia-Leal, T | 1 |
Serrano, LJ | 1 |
Borroni, E | 1 |
Kalandadze, V | 1 |
Galiano, R | 1 |
Borsotti, C | 1 |
Liras, A | 1 |
Sanchez, MJ | 1 |
Follenzi, A | 1 |
Moayeri, M | 1 |
Hawley, TS | 1 |
Hawley, RG | 1 |
Ide, LM | 1 |
Gangadharan, B | 1 |
Chiang, KY | 1 |
Doering, CB | 1 |
Spencer, HT | 1 |
3 other studies available for busulfan and Hemophilia A
Article | Year |
---|---|
Therapeutic potential of fetal liver cell transplantation in hemophilia A mice.
Topics: Animals; Busulfan; Endothelial Cells; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Ce | 2023 |
Correction of murine hemophilia A by hematopoietic stem cell gene therapy.
Topics: Animals; Blotting, Northern; Blotting, Southern; Blotting, Western; Bone Marrow Cells; Bone Marrow T | 2005 |
Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.
Topics: Animals; Antineoplastic Agents; Busulfan; Cyclophosphamide; Factor VIII; Genetic Therapy; Hematopoie | 2007 |